Presentations from ISPOR 2019

OHE staff recently attended the ISPOR annual conference in New Orleans. In this blog post, we share a selection of our presentations. OHE staff recently attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans.…

OHE staff recently attended the ISPOR annual conference in New Orleans. In this blog post, we share a selection of our presentations.

OHE staff recently attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans. In this blog post, we share a selection of our presentations.

Lies, Damned Lies and Cost-Effectiveness: Open-Source Models from Office of Health Economics

THE CLINICAL AND ECONOMIC VALUE OF GENETIC SEQUENCING IN CANCER CARE from Office of Health Economics

MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION MAKING? from Office of Health Economics

Real option value drugs: is it really an option? from Office of Health Economics

News & Insights

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Navigating the Landscape of Digital Health – United Kingdom

2021 OHE Annual Report to the Charity Commission

Supporting the Era of Green Pharmaceuticals in the UK

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

All Publications

Presentations from ISPOR 2019

Related News

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Funding Challenges in the Malaysian Health Care System

OHE at HESG Winter 2020